GL1X · GenesisL1 explorer

Research workbench

GII.17 KAWASAKI323 protruding domain in complex with nanobody nano-4

Analyse GII.17 KAWASAKI323 protruding domain in complex with nanobody nano-4 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5O02
Type
protein
Length
428 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Capsid protein; Nanobody (vhh) nano-4
UniProt
A0A0A7CJV4
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACapsid proteinprotein3046% helix, 35% strandA0A0A7CJV4
CNanobody (vhh) nano-4protein12410% helix, 50% strand—

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 6 copies · chains A, C
  • IMD · Imidazole · additive · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11310.420.7525empty
2510.280.7515empty

Interfaces

1 interface between chains.

  • A–C · 559 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 5O02 · GII.17 Kawasaki323 protruding domain in complex with Nanobody Nano-4 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.